Key Developments: McKesson Corp (MCK.N)
116.89USD
17 May 2013
$1.48 (+1.28%)
$115.41
$115.51
$117.00
$115.51
366,335
360,409
$117.20
$84.66
Latest Key Developments (Source: Significant Developments)
McKesson Corporation Declares Quarterly Dividend July 25, 2012
McKesson Corporation announced that it has declared a regular dividend of $.20 per share on Common Stock, payable on October 1, 2012, to stockholders of record on September 4, 2012. Full Article
McKesson Corporation Reaffirms FY 2013 Earnings Guidance
McKesson Corporation reaffirmed earnings guidance for fiscal 2013 and the underlying key assumptions provided in its press release of April 30, 2012. Full Article
McKesson Corporation Declares Quarterly Dividend
McKesson Corporation announced that it declared a regular dividend of twenty cents per share on Common Stock, payable on July 2, 2012, to stockholders of record on June 8, 2012. Full Article
McKesson Corporation Issues FY 2013 EPS Guidance In Line With Analysts' Estimates
McKesson Corporation announced that for fiscal 2013, it expects adjusted earnings between $7.05 and $7.35 per share. According to I/B/E/S Estimates, analysts were expecting the Company to report EPS of $7.19 for fiscal 2013. Full Article
Department of Veterans Affairs Selects McKesson Corporation As Prime Pharmaceutical Supplier To VA Healthcare System
McKesson Corporation announced that it has been selected by the Department of Veterans Affairs (VA), which runs the integrated healthcare system, to continue as the VA's prime pharmaceutical supplier. The two-year agreement calls for McKesson to supply all of the VA's medical centers and outpatient clinics, as well as the VA's Consolidated Mail Outpatient Pharmacies (CMOPs). As part of the contract award, McKesson will continue to supply pharmaceuticals to more than 700 locations, including more than 270 medical centers, as well as the VA's seven CMOPs. The initial two-year contract includes options for up to three, two-year extensions. Full Article
McKesson Corporation Completes Acquisition of Independent Banner And Franchise Businesses Of Katz Group Canada Inc.
McKesson Corporation announced that it has completed the previously announced acquisition of the independent banner and franchise businesses of Katz Group Canada Inc. in an all cash transaction that closed March 25th, 2012. Full Article
McKesson Corporation Reaffirms FY 2012 EPS Guidance
McKesson Corporation announced that for fiscal 2012, it expects adjusted earnings between $6.19 and $6.39 per diluted share (EPS). According to I/B/E/S Estimates, analysts were expecting the Company to report EPS of $6.33 for fiscal 2012. Full Article
McKesson Corporation To Acquire Independent Banner And Franchise Businesses Of Katz Group Canada Inc.
McKesson Corporation announced that it has signed a definitive agreement to purchase Drug Trading Company Limited, the independent banner business of Katz Group Canada Inc., and Medicine Shoppe Canada Inc., the franchise business of Katz Group. The acquisition demonstrates McKesson’s long-standing commitment to the health of the independent pharmacy segment in the Canadian market. The purchase price is approximately CAD920 million. The acquisition is expected to close in the first half of this calendar year, subject to customary closing conditions, including all necessary Canadian regulatory clearances. Under the terms of the agreement, McKesson will acquire substantially all of the assets of Drug Trading, which consists of a marketing and purchasing arm for a network of more than 850 independently-owned pharmacies located in Ontario, Western Canada and Atlantic Canada, the majority of which operate under the brands I.D.A. and Guardian. McKesson will also acquire Medicine Shoppe Canada Inc., which operates the franchise business of providing services to more than 160 independent pharmacies also located in Ontario, Western Canada and Atlantic Canada. McKesson has been the primary pharmaceutical distributor to the Drug Trading and Medicine Shoppe Canada independent pharmacies for many years. As part of the transaction, McKesson will also acquire joint ownership of the ProPharm software application, which supports pharmacy dispensary systems. Full Article
McKesson Corporation Declares Quarterly Dividend
McKesson Corporation announced that the Board of Directors declared a regular dividend of $0.2 per share on common Stock, payable on April 2, 2012, to stockholders of record on March 1, 2012. Full Article
McKesson Corporation Declares Quarterly Dividend
McKesson Corporation announced that it has declared a regular dividend of $0.20 per share on Common Stock, payable on January 3, 2012, to stockholders of record on December 1, 2011. Full Article
CORRECTED-BRIEF-McKesson Q4 results
(In May 7 story, corrects seventh bullet point to show analysts' estimate for 2014 profit was $8.06 per share, not $7.21)
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
